Not Yet RecruitingNot Applicable

Impact of Blood Glucose Levels on in ICU Morbidity and Mortality in Patients With Acute Decompensated Heart Failure

96 participantsStarted 2024-07-01

Plain-language summary

To evaluate the effect of blood glucose level at admission and glucose variability during ICU admission and their effect on in-hospital morbidity and mortality in patients admitted with acute decompensated heart failure

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients admitted with acute decompensated heart failure will be recruited in the study. Exclusion Criteria: * Patients on chronic steroid therapy Patients diagnosed with right sided heart failure due to chest disease Patients with malignancy

What they're measuring

To evaluate the effect of glucose variability during ICU admission on in-hospital morbidity and mortality in patients admitted with acute decompensated heart failure ▪

Timeframe: 1 year

Trial details

NCT IDNCT06453967

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-05-31

Contact for this trial

salma Hamdy, master degree

01012681274 salmahamdy003@gmail.com

View on ClinicalTrials.gov More Heart Failure trials